Cancer & Blood Disease Center is categorized under Hematologists in Lecanto, FL and active since 1983.
Cancer & Blood Disease Center was established in 1983, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Marie Chapman, Office Manager at the company’s single location by writing to 521 North Lecanto Highway, Lecanto, Florida FL 34461 or by phoning (352) 746-0707. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cancer & Blood Disease Center |
| Contact Person: | Marie Chapman, Office Manager |
| Address: | 521 North Lecanto Highway, Lecanto, Florida 34461 |
| Phone Number: | (352) 746-0707 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1983 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Cancer & Blood Disease Center was started in 1983 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Marie Chapman, Office Manager for inquiries that concern Cancer & Blood Disease Center by calling the company number (352) 746-0707, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer & Blood Disease Center can be found at the coordinates 28.86862,-82.48813 as well as the street address 521 North Lecanto Highway in Lecanto, Florida 34461.
For its online presence, you may visit Cancer & Blood Disease Center’s website at and engage with its social media outlets through on Twitter and on Facebook.